Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?
about
Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Evolving treatment strategies ...... or longer-term trial outcomes?
@en
Evolving treatment strategies ...... or longer-term trial outcomes?
@nl
type
label
Evolving treatment strategies ...... or longer-term trial outcomes?
@en
Evolving treatment strategies ...... or longer-term trial outcomes?
@nl
prefLabel
Evolving treatment strategies ...... or longer-term trial outcomes?
@en
Evolving treatment strategies ...... or longer-term trial outcomes?
@nl
P2860
P356
P1476
Evolving treatment strategies ...... or longer-term trial outcomes?
@en
P2860
P356
10.1111/BCP.13637
P407
P577
2018-06-03T00:00:00Z